A Critical Evaluation of the Clinical Evidence for Pomegranate Preparations in the Prevention and Treatment of Cardiovascular Diseases

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1573|29|4|501-508

ISSN： 0951-418x

Source： PHYTOTHERAPY RESEARCH, Vol.29, Iss.4, 2015-04, pp. : 501-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary prevention of cardiovascular diseases

By Sigurdsson Emil L. Thorgeirsson Gudmundur

Scandinavian Journal of Primary Health Care, Vol. 21, Iss. 2, 2003-01 ,pp. : 68-74

Informa Healthcare

Access to resources Recommend Favorite

Aspirin in the Treatment and Prevention of Cardiovascular Disease

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 3, 2004-11 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

Plant stanol and sterol esters in prevention of cardiovascular diseases

By Miettinen Tatu Gylling Helena

Annals of Medicine, Vol. 36, Iss. 2, 2004-04 ,pp. : 126-134

Informa Healthcare

Access to resources Recommend Favorite

Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

By Kokubo Yoshihiro

The EPMA Journal, Vol. 2, Iss. 1, 2011-03 ,pp. : 75-81

Springer Publishing Company

Access to resources Recommend Favorite

Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular disease

By Tuteja Sony Rader Daniel J

Personalized Medicine, Vol. 9, Iss. 4, 2012-06 ,pp. : 395-404

Future Medicine

Access to resources Recommend Favorite